William Ball, MD, Named Interim VP, College of Medicine Dean
CINCINNATIWilliam Ball, MD, has been appointed University of Cincinnati (UC) interim vice president for health affairs and dean of the College of Medicine, effective Nov. 1, 2014.
"Dr. Ball has a long and distinguished career as a clinician, researcher and senior leader at the University of Cincinnati and Cincinnati Childrens Hospital. His expertise and experience will enable the College of Medicine and the Academic Health Center to move forward with momentum, UC President Santa Ono, PhD, said.
Ball becomes the 51st dean in the colleges nearly 200-year history. Thomas Boat, MD, who has served as dean and vice president since July 1, 2011, announced Sept. 15 that he would step down.
As vice president for health affairs, Ball will lead the collaborative efforts of the universitys four health collegesallied health sciences, medicine, nursing and pharmacyin addition to guiding relationships with health care affiliates, including UC Health, Cincinnati Childrens Hospital Medical Center, Cincinnati Department of Veterans Affairs Medical Center and Shriners Hospitals for ChildrenCincinnati. The vice president and dean sits on the presidents executive committee and cabinet.
Ball currently serves as UC vice president for research and professor of radiology, biomedical engineering and pediatrics. He is former interim chair and chair of the department of biomedical engineering from 2001 to 2008. He received his medical degree from Tulane University School of Medicine, completed a fellowship in pediatric radiology and neuroradiology at Cincinnati Childrens and additional neuroradiology fellowship training at the University of New Mexico Medical Center before joining UC and Cincinnati Childrens in 1984.
Ball will remain vice president of research while he assumes these interim roles.
"I look forward to continuing the progress of the College of Medicine, moving it forward in this interim period, and preparing it for future permanent leadership, Ball said.
The university will engage an external consultant to assist in developing a broad-based, multi-stage process for determining the optimal organizational structure for advancing the mission, vision, values and priorities of the College of Medicine and the Academic Health Center, Ono and Beverly Davenport, PhD, senior vice president for academic affairs and provost, said in announcing the appointment.
"Once this assessment is complete, we will move forward on launching an international search for new leadership. While we will work expeditiously, we also will work wisely to ensure the process is strategic and inclusive, they wrote in an announcement to the university.
"We are grateful to Thomas Boat, MD, for his decades of dedicated leadership at the University of Cincinnati and Cincinnati Childrens. Dr. Boat has helped build the foundation of a great college and academic medical center, Ono said.
Founded in 1819, the UC College of Medicine is the second-oldest public medical school in the country and the oldest west of the Alleghenies. The College of Medicine has 680 medical students and 538 graduate students with 249 postdoctoral fellows and 1,060 residents and fellows serving UC Health University of Cincinnati Medical Center and Cincinnati Childrens Hospital Medical Center. With approximately 2,000 employees, including 1,649 faculty, the college has a total budget of more than $512 million. Deeply involved in research, the college and the affiliated Cincinnati Childrens received more than $260 million in research funding in 2013. Patient care is provided by University of Cincinnati Physicians, the colleges 750-member faculty group practice, and at University of Cincinnati Medical Center, the college's primary teaching hospital, and other area hospitals.
William Ball, MD, Christian R. Holmes Professor and Dean, College of Medicine, and senior vice president for health affairs
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.